The novel therapy of this peptide represents a major development in the handling of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide981622.dbblog.net/15359241/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment